| Eröffnung: | - |
| Veränderung: | - |
| Volumen: | - |
| Tief: | - |
| Hoch: | - |
| Hoch - Tief: | - |
| Typ: | Aktien |
| Ticker: | OFIX |
| ISIN: | ANN6748L1027 |
ORTHOFIX MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix Medical, Inc. - OFIX
- 142
PR Newswire
NEW ORLEANS, Oct. 4, 2024
NEW ORLEANS, Oct. 4, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc. (NasdaqGS: OFIX), if they purchased the Company's shares between October 11, 2022, and September 12, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of Texas.
Get Help
Orthofix investors should visit us at https://claimsfiler.com/cases/nasdaq-ofix-1/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Orthofix and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On September 12, 2023, the Company announced the appointment of an interim CEO, interim CFO, and interim CLO, effective immediately, following the "unanimous decision by the Board's independent directors to terminate for cause [President and CEO] Keith Valentine, [CFO] John Bostjancic and [CLO] Patrick Keran from those respective roles" due to an independent investigation that revealed that "each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company's values and culture."
On this news, the price of Orthofix's shares fell $5.62 per share, or over 30%, to close at $13.01 per share on September 13, 2023, on unusually heavy volume.
The case is Bernal v. Orthofix Medical, Inc., et al., No. 2:24-cv-00690.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
View original content:SOURCE ClaimsFiler
